Navigation Links
Scan Technology Tied to Overtreatment of Clots in Lungs
Date:5/9/2011

MONDAY, May 9 (HealthDay News) -- Overdiagnosis and overtreatment of pulmonary embolism is a problem in the United States due to the large increase in the use of computed tomography pulmonary angiography (CTPA), a new study suggests.

A pulmonary embolism (PE) is a potentially life-threatening blood clot in the lungs. CTPA was introduced in 1998 to improve detection of PE and its use has grown rapidly, according to background information in the study by Boston University School of Medicine researchers.

The investigators compared data about PE in U.S. adults before (1993-1998) and after (1998-2006) CTPA was introduced, and found that the incidence of PE increased 81 percent after CTPA became available, from 62.1 to 112.3 per 100,000 people.

Deaths from PE decreased during both time periods, but more so before (8 percent reduction, from 13.4 to 12.3 per 100,000), than after the introduction of CTPA (3 percent reduction, from 12.3 to 11.9 per 100,000 people), the research team reported.

There was also a slight improvement in case fatality before CTPA (8 percent decrease, from 13.2 to 12.1 percent of patients) and a substantial improvement after CTPA (36 percent decrease, from 12.1 to 7.8 percent of cases), according to the report published in the May 9 issue of the Archives of Internal Medicine.

While CTPA offers many benefits, the downside is that it can detect clots so small that they might never cause symptoms or death, yet the treatment for these clots, known as anti-clotting therapy, may be harmful to patients, the researchers said.

"Overdiagnosis matters because it can lead to [treatment-related] harm. While a clinically insignificant PE is by definition not harmful, treating such an embolism can cause harm such as bleeding from anticoagulation [anti-clotting therapy], which can -- in the worst case -- be fatal," lead author Dr. Renda Soylemez Wiener, an assistant professor of medicine, said in a university news release.

The frequency of presumed complications of anticoagulation for PE was stable before CTPA, but increased 71 percent (from 3.1 to 5.3 per 100,000) after CTPA became available, the study authors explained.

The problem of overdiagnosis and overtreatment of PE is likely to continue to grow, according to the study authors. They called for further research to determine whether some PE patients with small clots can safely forgo anticoagulation treatment.

More information

The Society for Vascular Surgery has more about pulmonary embolism.

-- Robert Preidt

SOURCE: Boston University Medical Center, news release, May 9, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Three NHS Trusts Choose BigHand Voice Technology Under YHCPC Framework Agreement
2. Gold at Forefront of Nanotechnology Revolution
3. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
4. Embark Health Selects the Jellyvision Lab's Interactive Conversation Technology to Educate Website Visitors on Advance Directives
5. First Breakthrough in Water Heating Technology!
6. New Technology Could Widen Reach of Vaccines
7. WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010
8. Nanotechnology could help Arab region
9. Genetic health risks in children of assisted reproductive technology
10. Mennen Medical Launches the VitaLogik 6000, a Pre-Configured Multi-Parameter Patient Monitor with New High Performance Wireless Technology
11. New cardiac CT technology drastically reduces patient radiation exposure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scan Technology Tied to Overtreatment of Clots in Lungs
(Date:2/13/2016)... ... ... in Sun City is the place to be on March 3rd to learn about the ... be hosting this educational seminar from 5:30 p.m. – 7:00 p.m. Exciting advancements will be ... In addition, prizes will be given away and light refreshments will be served. , ...
(Date:2/13/2016)... Coral Springs, FL (PRWEB) , ... February 13, 2016 , ... ... on the environmental impact of American businesses. , The increasingly modern world of ... rely more often on non-renewable energy sources such as oil and coal, which pollutes ...
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... ... 12, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... at its 10th anniversary Fashion Luncheon on Monday, February 8, 2016. The special ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of coconut ... Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities the ... the big event. The invitation-only gifting suite, held this year at the W Hollywood ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 2016  Sequent Medical, Inc. announced today that it ... the safety and effectiveness of the WEB™ Aneurysm Embolization ... aneurysms.  Prof Laurent Spelle , MD, Head of ... France and Principal Investigator of the CLARYS ... and Germany.  Although patients with ruptured aneurysms ...
(Date:2/12/2016)... 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ) ... will ring the Nasdaq Closing Bell at the Nasdaq ... at 4:00 p.m. ET on Tuesday, February 16, ... Adrian Adams , will perform the honorary bell ... p.m. ET.  A live webcast will be available at: ...
(Date:2/12/2016)... 12, 2016 Indiso ... den ungedeckten medizinischen Bedarf bei Lungen- und ... klinischen Forschungsprogramms bekannt. Das Programm, das sich ... ihrer respiratorischen Funktionen und anderer klinischer Parameter. ... Medizintechnikunternehmen, das sich auf den ungedeckten medizinischen ...
Breaking Medicine Technology: